International Journal of Oncology

Article	Citations
Nuclear miRNAs as transcriptional regulators in processes related to various cancers (Review)	210
Identification and characterization of slow‑cycling cells in Ewing sarcoma	78
Aberrant alternative splicing in cancer: Splicing events and their regulatory mechanisms (Review)	73
[Retracted] Fbxw7 regulates hepatocellular carcinoma migration and invasion via Notch1 signaling pathway	69
Roles of voltage‑gated potassium channels in the maintenance of pancreatic cancer stem cells	60
Histone lysine demethylase 3B regulates autophagy via transcriptional regulation of GABARAPL1 in acute myeloid leukemia cells	58
Anti‑angiogenic effect of Bryopsis plumosa‑derived peptide via aquaporin 3 in non‑small cell lung cancer	53
[Corrigendum] Dual targeting of glioblastoma multiforme with a proteasome inhibitor (Velcade) and a phosphatidylinositol 3‑kinase inhibitor (ZSTK474)	52
DNA methylation and breast cancer: A way forward (Review)	49
miR‑383 increases the cisplatin sensitivity of lung adenocarcinoma cells through inhibition of the RBM24‑mediated NF‑κB signaling pathway	49
Effect of DPP4/CD26 expression on SARS‑CoV‑2 susceptibility, immune response, adenosine (derivatives m62A and CD) regulations on patients with cancer and healthy individuals	48
Tumor suppressive functions of hsa‑miR‑34a on cell cycle, migration and protective autophagy in bladder cancer	46
Butyrate supplementation regulates expression of chromosome segregation 1‑like protein to reverse the genetic distortion caused by p53 mutations in colorectal cancer	44
Role of miR‑181a‑5p in cancer (Review)	43
Modulation of PD‑L1 expression by standard therapy in head and neck cancer cell lines and exosomes	42
Human‑made electromagnetic fields: Ion forced‑oscillation and voltage‑gated ion channel dysfunction, oxidative stress and DNA damage (Review)	36
From mitochondrial dysregulation to ferroptosis: Exploring new strategies and challenges in radioimmunotherapy (Review)	36
[Retracted] Interaction of YAP1 and mTOR promotes bladder cancer progression	33
[Retracted] Feroniellin A‑induced autophagy causes apoptosis in multidrug‑resistant human A549 lung cancer cells	33
Cinobufagin inhibits M2‑like tumor‑associated macrophage polarization to attenuate the invasion and migration of lung cancer cells	32
Epigenetic and epitranscriptomic role of lncRNA in carcinogenesis (Review)	32
Targeting the cuproptosis‑associated gene COL22A1 in glioblastoma using EMD‑1204831 and kaempferol	32
Genome‑wide DNA hypomethylation drives a more invasive pancreatic cancer phenotype and has predictive occult distant metastasis and prognosis potential	31
Targeting PIM2 by JP11646 results in significant antitumor effects in solid tumors	31
[Retracted] Interaction of S100A1 with LATS1 promotes cell growth through regulation of the Hippo pathway in hepatocellular carcinoma	30

Potential role of the bitter taste receptor T2R14 in the prolonged survival and enhanced chemoresponsiveness induced by apigenin	29
GSTO1 confers drug resistance in HCT‑116 colon cancer cells through an interaction with TNFαIP3/A20	28
Molecular mechanisms and targeted therapy for the metastasis of prostate cancer to the bones (Review)	28
RAD51 and PALB2 in precision oncology: Clinical implications for HRD associated breast and ovarian cancers (Review)	27
Endocrine nuclear receptors and long non‑coding RNAs reciprocal regulation in cancer (Review)	26
Human cytomegalovirus infection enhances 5‑lipoxygenase and cycloxygenase‑2 expression in colorectal cancer	26
[Corrigendum] HIF-1α contributes to tube malformation of human lymphatic endothelial cells by upregulating VEGFR-3	25
Transgelin promotes ferroptosis to inhibit the malignant progression of esophageal squamous cell carcinoma	25
VIM‑AS1 promotes proliferation and drives enzalutamide resistance in prostate cancer via IGF2BP2‑mediated HMGCS1 mRNA stabilization	24
Current updates on the structural and functional aspects of the CRISPR/Cas13 system for RNA targeting and editing: A next‑generation tool for cancer management (Review)	24
Advancements in colorectal cancer research: Unveiling the cellular and molecular mechanisms of neddylation (Review)	24
AUP1 transcriptionally activated by KDM5B reprograms lipid metabolism to promote the malignant progression of cervical cancer	24
[Corrigendum] Receptor for activated C kinase 1 (RACK1) promotes the progression of OSCC via the AKT/mTOR pathway	24
Polydatin, a potential NOX5 agonist, synergistically enhances antitumor activity of cisplatin by stimulating oxidative stress in non‑small cell lung cancer	24
Abnormal expression of CDC25C in NSCLC is influenced by transcriptional and RNA N6‑methyladenosine‑mediated post‑transcriptional regulation	23
[Corrigendum] (‑)‑Epigallocatechingallate induces apoptosis in B lymphoma cells via caspase‑dependent pathway and Bcl‑2 family protein modulation	23
[Corrigendum] Downregulation of CD147 induces malignant melanoma cell apoptosis via the regulation of IGFBP2 expression	23
Aberrant acetylated modification of FGF21‑KLB signaling contributes to hepatocellular carcinoma metastasis through the β‑catenin pathway	21
[Retracted] MicroRNA‑132 inhibits cell growth and metastasis in osteosarcoma cell lines possibly by targeting Sox4	21
Beyond the tumor microenvironment: Orchestrating systemic T‑cell response for next‑generation cancer immunotherapy (Review)	21
A multi‑omics study of diagnostic markers and the unique inflammatory tumor micro‑environment involved in tuberous sclerosis complex‑related renal angiomyolipoma	21
Ageing microenvironment mediates lymphocyte carcinogenesis and lymphoma drug resistance: From mechanisms to clinical therapy (Review)	21
Regulation of gliomagenesis and stemness through acid sensor ASIC1a	21
[Corrigendum] DJ‑1 promotes cell proliferation and tumor metastasis in esophageal squamous cell carcinoma via the Wnt/β‑catenin signaling pathway	21
Arsenic compounds induce apoptosis by activating the MAPK and caspase pathways in FaDu oral squamous carcinoma cells	20
Cryptotanshinone suppresses tumorigenesis by inhibiting lipogenesis and promoting reactive oxygen species production in KRAS‑activated pancreatic cancer cells	20
[Corrigendum] Long non‑coding RNA CASC11 interacts with YBX1 to promote prostate cancer progression by suppressing the p53 pathway	20
GDNF regulates lipid metabolism and glioma growth through RET/ERK/HIF‑1/SREBP‑1	20
[Retracted] miR‑802 inhibits the aggressive behaviors of non‑small cell lung cancer cells by directly targeting FGFR1	20
Role of miRNA‑122 in cancer (Review)	19
Revolutionizing breast cancer treatment: Harnessing the related mechanisms and drugs for regulated cell death (Review)	19
Anti‑PD‑1/PD‑L1 and anti‑CTLA‑4 associated checkpoint inhibitor pneumonitis in non‑small cell lung cancer: Occurrence, pathogenesis and risk factors (Review)	19
[Retracted] Effects of RUNX3 mediated Notch signaling pathway on biological characteristics of colorectal cancer cells	19
Prolyl hydroxylase 2 inhibits glycolytic activity in colorectal cancer via the NF‑κB signaling pathway	18
An overview of the regulatory role of annexin A1 in the tumor microenvironment and its prospective clinical application (Review)	18
Research progress on PRMTs involved in epigenetic modification and tumour signalling pathway regulation (Review)	18
lncRNA deregulation in childhood acute lymphoblastic leukemia: A systematic review	18
Tumor immune microenvironment and the current immunotherapy of cholangiocarcinoma (Review)	18
[Corrigendum] miR-382 inhibits migration and invasion by targeting ROR1 through regulating EMT in ovarian cancer	18
[Retracted] MicroRNA‑873 targets HOXA9 to inhibit the aggressive phenotype of osteosarcoma by deactivating the Wnt/β‑catenin pathway	18
The regulatory effect of the YY1/miR‑HCC2/BAMBI axis on the stemness of liver cancer cells	18
Aurantio‑obtusin regulates lipogenesis and ferroptosis of liver cancer cells through inhibiting SCD1 and sensitizing RSL3	18
Liproxstatin‑1 induces cell cycle arrest, apoptosis, and caspase‑3/GSDME‑dependent secondary pyroptosis in K562 cells	17
Effect of duty cycles of tumor‑treating fields on glioblastoma cells and normal brain organoids	17
[Retracted] NR4A1‑induced increase in the sensitivity of a human gastric cancer line to TNFα‑mediated apoptosis is associated with the inhibition of JNK/Parkin‑dependent mitophagy	17
HepaCAM‑PIK3CA axis regulates the reprogramming of glutamine metabolism to inhibit prostate cancer cell proliferation	17
[Retracted] Promoter methylation of RASSF1A modulates the effect of the microtubule‑targeting agent docetaxel in breast cancer	17
Emerging proteins involved in castration‑resistant prostate cancer via the AR‑dependent and AR‑independent pathways (Review)	17
Significance of signal recognition particle 9 nuclear translocation: Implications for pancreatic cancer prognosis and functionality	16
LGR4 promotes proliferation and homing via activation of the NF‑κB signaling pathway in multiple myeloma	16

GBP2 enhances paclitaxel sensitivity in triple‑negative breast cancer by promoting autophagy in combination with ATG2 and inhibiting the PI3K/AKT/mTOR pathway	16
Novel non‑metal‑based contrast agents for MR imaging: Emerging approaches and clinical perspectives (Review)	16
Antitumor effect of memantine is related to the formation of the splicing isoform of GLG1, a decoy FGF‑binding protein	16
Role of DCLK1 in oncogenic signaling (Review)	16
[Retracted] MicroRNA‑664 targets paired box protein 6 to inhibit the oncogenicity of pancreatic ductal adenocarcinoma	16
RPL9 acts as an oncogene by shuttling miRNAs through exosomes in human hepatocellular carcinoma cells	15
miR‑382 inhibits breast cancer progression and metastasis by affecting the M2 polarization of tumor‑associated macrophages by targeting PGC‑1α	15
Emerging role of bile acids in colorectal liver metastasis: From molecular mechanism to clinical significance (Review)	15
Mechanism of exosomes in the tumor microenvironment in the abscopal effect (Review)	15
Exosome as a crucial communicator between tumor microenvironment and gastric cancer (Review)	15
Complement regulatory protein CD46 promotes bladder cancer metastasis through activation of MMP9	15
[Retracted] Tripartite motif 16 inhibits hepatocellular carcinoma cell migration and invasion	15
Targeting the mTOR pathway using novel ATP‑competitive inhibitors, Torin1, Torin2 and XL388, in the treatment of glioblastoma	14
[Corrigendum] Adenoviral neutral endopeptidase gene delivery in combination with paclitaxel for the treatment of prostate cancer	14
FGFR‑related phenotypic and functional profile of CAFs in prognostication of breast cancer (Review)	14
LncCCAT1 interaction protein PKM2 upregulates SREBP2 phosphorylation to promote osteosarcoma tumorigenesis by enhancing the Warburg effect and lipogenesis	14
Ex vivo assessment of cancer drug sensitivity in epithelial ovarian cancer and its association with histopathological type, treatment history and clinical outcome	14
[Corrigendum] The role of IGFBP‑5 in mediating the anti‑proliferation effect of tetrandrine in human colon cancer cells	14
MELK predicts poor prognosis and promotes metastasis in esophageal squamous cell carcinoma via activating the NF‑κB pathway	14
Cucurbitacin IIa promotes the immunogenic cell death‑inducing effect of doxorubicin and modulates immune microenvironment in liver cancer	14
Biological functions of circRNA in regulating the hallmarks of gastrointestinal cancer (Review)	14
Epigenetic silencing of ZCCHC10 by the lncRNA SNHG1 promotes progression and venetoclax resistance of acute myeloid leukemia	14
lncRNA SNHG22 sponges miR‑128‑3p to promote the progression of colorectal cancer by upregulating E2F3	13
Establishment of patient‑derived lung tumorspheres and their response to internal irradiation by Auger electrons	13
[Corrigendum] Linc00961 inhibits the proliferation and invasion of skin melanoma by targeting the miR‑367/PTEN axis	13
[Corrigendum] METTL3 antagonizes 5‑FU chemotherapy and confers drug resistance in colorectal carcinoma	13
Correlation of SARS‑CoV‑2 to cancer: Carcinogenic or anticancer? (Review)	13
Chimeric HDAC and the cytoskeleton inhibitor broxbam as a novel therapeutic strategy for liver cancer	13
[Corrigendum] Wnt‑signaling and apoptosis after neoadjuvant short‑term radiotherapy for rectal cancer	13
Effects of exosomes on tumor immunomodulation and their potential clinical applications (Review)	13
MicroRNA in adenoid cystic carcinoma (Review)	13
[Retracted] Expression and function of PIM kinases in osteosarcoma	13
Targeting mitochondrial bioenergetics by combination treatment with imatinib and dichloroacetate in human erythroleukemic K‑562 and colorectal HCT‑116 cancer cells	13
Targeting drug resistance in glioblastoma (Review)	12
[Retracted] lncRNA PLAC2 activated by H3K27 acetylation promotes cell proliferation and invasion via the activation of Wnt/β‑catenin pathway in oral squamous cell carcinoma	12
Tumour follower cells: A novel driver of leader cells in collective invasion (Review)	12
Identification of recurrent 3q13.31 chromosomal rearrangement indicates LSAMP as a tumor suppressor gene in neuroblastoma	12
[Retracted] Slug contributes to cancer progression by direct regulation of ERα signaling pathway	12
Controversial roles of cold‑inducible RNA‑binding protein in human cancer (Review)	12
[Corrigendum] Metastasis suppressor 1 expression in human ovarian cancer: The impact on cellular migration and metastasis	12
Antimicrobial agent chloroxylenol targets β‑catenin‑mediated Wnt signaling and exerts anticancer activity in colorectal cancer	12
Roles of salt‑inducible kinases in cancer (Review)	12
Epigenetic modifications in acute myeloid leukemia: The emerging role of circular RNAs (Review)	12
lncRNA cytoskeleton regulator reduces non‑small cell lung cancer radiosensitivity by downregulating miRNA‑206 and activating prothymosin α	12
Visfatin inhibits colon cancer cell apoptosis and decreases chemosensitivity to 5‑FU by promoting the SDF‑1/CXCR4/Akt axis	12
Circular RNAs in osteosarcoma: An update of recent studies (Review)	12
Protein lactylation and immunotherapy in gliomas: A novel regulatory axis in tumor metabolism (Review)	12
RPL27 contributes to colorectal cancer proliferation and stemness via PLK1 signaling	12
m6A‑modified HOXC10 promotes HNSCC progression via co‑activation of ADAM17/EGFR and Wnt/β‑catenin signaling	12
Lnc‑RGS5 sponges miR‑542‑5p to promote FoxM1/VEGFA signaling and breast cancer cell proliferation	12
Ribosome 18S m6A methyltransferase METTL5 promotes pancreatic cancer progression by modulating c‑Myc translation	12
Use of conditional reprogramming cell, patient derived xenograft and organoid for drug screening for individualized prostate cancer therapy: Current and future perspectives (Review)	12
Receptor for activated C kinase 1 promotes cervical cancer lymph node metastasis via the glycolysis‑dependent AKT/mTOR signaling	12
[Corrigendum] Curcumin reverses benzidine-induced epithelial-mesenchymal transition via suppression of ERK5/AP-1 in SV-40 immortalized human urothelial cells	11
Epigallocatechin‑3‑gallate hinders metabolic coupling to suppress colorectal cancer malignancy through targeting aerobic glycolysis in cancer‑associated fibroblasts	11
USP35 promotes hepatocellular carcinoma progression by protecting PKM2 from ubiquitination‑mediated degradation	11
Chimeric antigen receptor T cells in the treatment of osteosarcoma (Review)	11
[Corrigendum] SMC1A promotes growth and migration of prostate cancer in vitro and in vivo	11
[Corrigendum] The mechanism of adenosine‑mediated activation of lncRNA MEG3 and its antitumor effects in human hepatoma cells	11
Galectin‑1 binds GRP78 to promote the proliferation and metastasis of gastric cancer	11
Function of microRNA‑124 in the pathogenesis of cancer (Review)	11
Tumor suppressive functions of WNT5A in rhabdomyosarcoma	11
Lactoferrin may inhibit the development of cancer via its immunostimulatory and immunomodulatory activities	11
Death associated protein‑3 (DAP3) and DAP3 binding cell death enhancer‑1 (DELE1) in human colorectal cancer, and their impacts on clinical outcome and chemoresistance	11
Inhibition of the NOTCH and mTOR pathways by nelfinavir as a novel treatment for T cell acute lymphoblastic leukemia	11
New developments in the mechanism and application of immune checkpoint inhibitors in cancer therapy (Review)	11
Gefitinib enhances the anti‑tumor immune response against EGFR‑mutated NSCLC by upregulating B7H5 expression and activating T cells via CD28H	11
Signaling pathways and therapeutic approaches in glioblastoma multiforme (Review)	10
Role of microRNAs in glycolysis in gynecological tumors (Review)	10
Impact of PD‑L1 upregulation on immune checkpoint inhibitor efficacy in triple‑negative breast cancer using a 4T1 murine model	10
[Corrigendum] High PLK4 expression promotes tumor progression and induces epithelial‑mesenchymal transition by regulating the Wnt/β‑catenin signaling pathway in colorectal cancer	10
Activation of DDX58/RIG‑I suppresses the growth of tumor cells by inhibiting STAT3/CSE signaling in colon cancer	10
Exosomal integrins in tumor progression, treatment and clinical prediction (Review)	10
TGF‑β inhibitor RepSox suppresses osteosarcoma via the JNK/Smad3 signaling pathway	10
Role and research progress of spasmolytic polypeptide‑expressing metaplasia in gastric cancer (Review)	10
New insights into lipid metabolism and prostate cancer (Review)	10
KDM5B protein expressed in viable and fertile ΔARID mice exhibit no demethylase activity	10
P2Y2R‑mediated transactivation of VEGFR2 through Src phosphorylation is associated with ESM‑1 overexpression in radiotherapy‑resistant‑triple negative breast cancer cells	10
[Corrigendum] STAT3 activation in HER2‑overexpressing breast cancer promotes epithelial‑mesenchymal transition and cancer stem cell traits	10
Role of exosomal non‑coding RNAs in cancer‑associated fibroblast‑mediated therapy resistance (Review)	10

[Retracted] miR‑222 regulates sorafenib resistance and enhance tumorigenicity in hepatocellular carcinoma	10
Induction of ferroptosis by SIRT1 knockdown alleviates cytarabine resistance in acute myeloid leukemia by activating the HMGB1/ACSL4 pathway	10
[Corrigendum] Role of the EZH2/miR‑200 axis in STAT3‑mediated OSCC invasion	9
Hyperthermia reduces cancer cell invasion and combats chemoresistance and immune evasion in human bladder cancer	9
Dual inhibition of EGFR‑VEGF: An effective approach to the treatment of advanced non‑small cell lung cancer with EGFR mutation (Review)	9
Increased expression of PSME2 is associated with clear cell renal cell carcinoma invasion by regulating BNIP3‑mediated autophagy	9
Elevation of ADAM12 facilitates tumor progression by enhancing metastasis and immune infiltration in gastric cancer	9
Role of N6‑methyladenosine in the pathogenesis, diagnosis and treatment of pancreatic cancer (Review)	9
[Retracted] MicroRNA‑30e inhibits adhesion, migration, invasion and cell cycle progression of prostate cancer cells via inhibition of the activation of the MAPK signaling pathway by downregulating CHR	9
[Corrigendum] CXCR1 promotes malignant behavior of gastric cancer cells in vitro and in vivo in AKT and ERK1/2 phosphorylation	9
The apelin‑apelin receptor signaling pathway in fibroblasts is involved in tumor growth via p53 expression of cancer cells	9
SUCLG1 promotes aerobic respiration and progression in plexiform neurofibroma	9
Altered expression of the IGF2‑H19 locus and mitochondrial respiratory complexes in adrenocortical carcinoma	9
Mechanisms and management of 3rd‑generation EGFR‑TKI resistance in advanced non‑small cell lung cancer (Review)	9
Artificial intelligence in cancer pathology: Challenge to meet increasing demands of precision medicine	9
[Corrigendum] Effect of duty cycles of tumor‑treating fields on glioblastoma cells and normal brain organoids	9
[Retracted] Sequential use of protein kinase inhibitors potentiates their toxicity to melanoma cells: A rationale to combine targeted drugs based on protein expression inhibition profiles	9
Spine‑specific downregulation of LAPTM5 expression promotes the progression and spinal metastasis of estrogen receptor‑positive breast cancer by activating glutamine‑dependent mTOR signaling	9
Keratin19 promotes pancreatic cancer progression and poor prognosis via activating the Hedgehog pathway	9
Extracellular vesicle‑mediated miR‑126‑3p transfer contributes to inter‑cellular communication in the liver tumor microenvironment	9
[Retracted] MicroRNA‑511 inhibits malignant behaviors of breast cancer by directly targeting SOX9 and regulating the PI3K/Akt pathway	9
[Corrigendum] The targeting of MTDH by miR‑145‑5p or miR‑145‑3p is associated with prognosis and regulates the growth and metastasis of prostate cancer cells	9
[Retracted] SIRT3 regulates cell proliferation and apoptosis related to energy metabolism in non‑small cell lung cancer cells through deacetylation of NMNAT2	8
Research progress on the role of tumor‑associated macrophages in tumor development and their use as molecular targets (Review)	8
Curcumin inhibits the cancer‑associated fibroblast‑derived chemoresistance of gastric cancer through the suppression of the JAK/STAT3 signaling pathway	8
LINC00514 promotes lipogenesis and tumor progression in esophageal squamous cell carcinoma by sponging miR‑378a‑5p to enhance SPHK1 expression	8
Molecular targets of primary cilia defects in cancer (Review)	8
Stromal cells in the tumor microenvironment promote the progression of oral squamous cell carcinoma	8
Landscape of circular RNAs in different types of lung cancer and an emerging role in therapeutic resistance (Review)	8
Knockdown of PGBD5 inhibits the malignant progression of glioma through upregulation of the PPAR pathway	8
Pan‑cancer analyses reveal the regulation and clinical outcome association of PCLAF in human tumors	8
S100 protein family: Emerging role and mechanism in digestive tract cancer (Review)	8
Adjusting for comorbidity in observational cancer studies: A systematic review to assess alignment between index and study	8
circ‑LRP6 contributes to osteosarcoma progression by regulating the miR‑141‑3p/HDAC4/HMGB1 axis	8
NcRNAs: Multi‑angle participation in the regulation of glioma chemotherapy resistance (Review)	8
Characterization of KIF20B as a novel prognostic biomarker and therapeutic target for breast cancer	7
Current developments of pharmacotherapy targeting heme oxygenase 1 in cancer (Review)	7
Upregulation of the EGFR/MEK1/MAPK1/2 signaling axis as a mechanism of resistance to antiestrogen‑induced BimEL dependent apoptosis in ER+ breast cancer cells	7
Treatment of patients with cancer using PD‑1/PD‑L1 antibodies: Adverse effects and management strategies (Review)	7
Transcription factor E2F4 facilitates SUMOylation to promote HCC progression through interaction with LIN9	7
Cx32 promotes autophagy and produces resistance to SN‑induced apoptosis via activation of AMPK signalling in cervical cancer	7
WBSCR22 and TRMT112 synergistically suppress cell proliferation, invasion and tumorigenesis in pancreatic cancer via transcriptional regulation of ISG15	7
Knockdown of lncRNA MALAT1 induces pyroptosis by regulating the miR‑124/SIRT1 axis in cervical cancer cells	7
[Corrigendum] S100A9 promotes the proliferation and invasion of HepG2 hepatocellular carcinoma cells via the activation of the MAPK signaling pathway	7
Pathogenetic development, diagnosis and clinical therapeutic approaches for liver metastasis from colorectal cancer (Review)	7
Advances in immune therapies for the treatment of microsatellite instability‑high/deficient mismatch repair metastatic colorectal cancer (Review)	7
[Retracted] Silencing the long noncoding RNA, TINCR, a molecular sponge of miR‑335, inhibits the malignant phenotype of epithelial ovarian cancer via FGF2 suppression	7
[Retracted] SRF‑miR‑29b‑MMP2 axis inhibits NSCLC invasion and metastasis	7
Effects of gut microbiome and obesity on the development, progression and prevention of cancer (Review)	7
RNA binding proteins in extracellular vesicles and their potential value for cancer diagnosis and treatment (Review)	7
High farnesoid X receptor expression predicts favorable clinical outcomes in PD‑L1low/negative non‑small cell lung cancer patients receiving anti‑PD‑1‑based chemo‑immunotherapy	7
DYRK1A-mediated PLK2 phosphorylation regulates the proliferation and invasion of glioblastoma cells	7
The TLR7/8 agonist R848 optimizes host and tumor immunity to improve therapeutic efficacy in murine lung cancer	7
A novel ferroptosis‑related gene signature for overall survival prediction and immune infiltration in patients with breast cancer	7
Role of the Wnt signaling pathway in the complex microenvironment of breast cancer and prospects for therapeutic potential (Review)	7
The important regulatory roles of circRNA‑encoded proteins or peptides in cancer pathogenesis (Review)	7
Potential of antiviral drug oseltamivir for the treatment of liver cancer	6
Pilot trial of topical MTS‑01 application to reduce dermatitis in patients receiving chemoradiotherapy for stage I‑III carcinoma of the anal canal	6
N6‑methyladenosine upregulates miR‑181d‑5p in exosomes derived from cancer‑associated fibroblasts to inhibit 5‑FU sensitivity by targeting NCALD in colorectal cancer	6
Decoding long non‑coding RNAs: Friends and foes in cancer development (Review)	6
Impact of obesity‑associated myeloid‑derived suppressor cells on cancer risk and progression (Review)	6
Long non‑coding RNA ABHD11‑AS1 inhibits colorectal cancer progression through interacting with EGFR to suppress the EGFR/ERK signaling pathway	6
Targeting the Hippo pathway to prevent radioresistance brain metastases from the lung (Review)	6
MicroRNA‑21: A potential therapeutic target in lung cancer (Review)	6
TRAP1 regulates the response of colorectal cancer cells to hypoxia and inhibits ribosome biogenesis under conditions of oxygen deprivation	6
Characterization of Opa interacting protein 5 as a new biomarker and therapeutic target for oral cancer	6
lncRNA GAS5, as a ceRNA, inhibits the proliferation of diffuse large B‑cell lymphoma cells by regulating the miR‑18a‑5p/RUNX1 axis	6
Expression of cellular retinoic acid binding protein 1 predicts peritoneal recurrence of gastric cancer	6
CUDC‑101 is a potential target inhibitor for the EGFR‑overexpression bladder cancer cells	6
Ovarian tumor deubiquitinase 6A regulates cell proliferation via deubiquitination of nucleolin and caspase‑7	6
HDAC inhibitors target IRS4 to enhance anti‑AR therapy in AR‑positive triple‑negative breast cancer	6
Roles of m6A modification in oral cancer (Review)	6
Laying the groundwork for the Biobank of Rare Malignant Neoplasms at the service of the Hellenic Network of Precision Medicine on Cancer	6
Targeting neddylation as a novel approach to lung cancer treatment (Review)	6
A novel lncRNA 495810 promotes the aerobic glycolysis in colorectal cancer by stabilizing pyruvate kinase isozyme M2	6
[Corrigendum] Fully human VEGFR2 monoclonal antibody BC001 attenuates tumor angiogenesis and inhibits tumor growth	6
Immunomodulatory antitumor effect of interferon‑beta combined with gemcitabine in pancreatic cancer	6
N6‑methyladenosine‑induced long non‑coding RNA PVT1 regulates the miR‑27b‑3p/BLM axis to promote prostate cancer progression	6
A perspective on the chemical structures and molecular mechanisms of curcumin and its derivatives and analogs in cancer treatment (Review)	6
[Retracted] miR‑486 suppresses the development of osteosarcoma by regulating PKC‑δ pathway	5
PPM1G and its diagnostic, prognostic and therapeutic potential in HCC (Review)	5
Anti‑silencing function 1B promotes the progression of pancreatic cancer by activating c‑Myc	5
Claudin‑9 is a novel prognostic biomarker for endometrial cancer	5
Research progress on immunotherapy in triple‑negative breast cancer (Review)	5
[Retracted] MicroRNA‑488 inhibits proliferation, invasion and EMT in osteosarcoma cell lines by targeting aquaporin 3	5
Treatment optimization of locally advanced and metastatic pancreatic cancer (Review)	5
Beyond tumor‑associated macrophages involved in spheroid formation and dissemination: Novel insights for ovarian cancer therapy (Review)	5
An emerging role of radiation‑induced exosomes in hepatocellular carcinoma progression and radioresistance (Review)	5
Strategies for neoantigen screening and immunogenicity validation in cancer immunotherapy (Review)	5
The EDN1/EDNRA/β‑arrestin axis promotes colorectal cancer progression by regulating STAT3 phosphorylation	5
Discovery of a potent cytotoxic agent that promotes G2/M phase cell cycle arrest and apoptosis in a malignant human pharyngeal squamous carcinoma cell line	5
Cellular metabolism in pancreatic cancer as a tool for prognosis and treatment (Review)	5
Exosomes from PYCR1 knockdown bone marrow mesenchymal stem inhibits aerobic glycolysis and the growth of bladder cancer cells via regulation of the EGFR/PI3K/AKT pathway	5
PD‑1/PD‑L1 immune checkpoint inhibitors in neoadjuvant therapy for solid tumors (Review)	5
Downregulation of miR‑7 and miR‑153 is involved in Helicobacter pylori CagA induced gastric carcinogenesis and progression	5